These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30479769)

  • 1. Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis.
    Brattås MK; Lilleeng K; Hovland R; Lægreid IJ; Vorland M; Leh F; Bruserud Ø; Gjertsen BT; Reikvam H
    Biomark Res; 2018; 6():33. PubMed ID: 30479769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
    BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of double positive myeloproliferative neoplasm: A diagnostic and therapeutic challenge.
    Shaikh AB; Aribandi A; Gupta A; Subramanian SK; Goyal M
    Indian J Pathol Microbiol; 2021; 64(4):820-823. PubMed ID: 34673614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of breakpoint cluster region-Abelson1 rearrangement and Janus kinase 2 V617F mutation in chronic myeloid leukemia: A case report.
    Shi XB; Jiang JF; Jin FX; Cheng W
    World J Clin Cases; 2019 May; 7(9):1087-1092. PubMed ID: 31123683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases.
    Yang YN; Qin YW; Wang C
    Oncol Lett; 2014 Aug; 8(2):841-844. PubMed ID: 25013507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review.
    Yue Y; Wei W; Guo Y; Wang F; Dong W; Liu Y; Lin Y; Cao Y; Gu W
    Am J Case Rep; 2020 Oct; 21():e925151. PubMed ID: 33021971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From primary myelofibrosis to chronic myeloid leukemia,
    Wang D; Kamata W; Ye F; You MJ
    EJHaem; 2024 Feb; 5(1):157-161. PubMed ID: 38406521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.
    Hummel JM; Kletecka MC; Sanks JK; Chiselite MD; Roulston D; Smith LB; Czuchlewski DR; Elenitoba-Johnson KS; Lim MS
    Diagn Mol Pathol; 2012 Sep; 21(3):176-83. PubMed ID: 22847163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case Report of
    Ali EAH; Al-Akiki S; Yassin MA
    Case Rep Oncol; 2021; 14(1):690-694. PubMed ID: 34054462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative disease.
    Elnaggar MM; Agersborg S; Sahoo T; Girgin A; Ma W; Rakkhit R; Zorrilla I; Leal A
    Mol Cytogenet; 2012 May; 5(1):23. PubMed ID: 22549126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BCR-ABL1-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the JAK2-V617F mutation].
    Amemiya A; Ito Y; Ishibashi Y; Saito Y; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Tanaka Y; Fujimoto H; Okabe S; Gotoh M; Tauchi T; Ohyashiki K
    Rinsho Ketsueki; 2017; 58(4):298-302. PubMed ID: 28484156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acute myeloid leukemia with e6a2 BCR-ABL fusion transcript acquired after progressing from chronic myelomonocytic leukemia.
    Yao J; Douer D; Wang L; Arcila ME; Nafa K; Chiu A
    Leuk Res Rep; 2017; 7():17-19. PubMed ID: 28275539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 (V617F) positive primary myelofibrosis.
    Pierini T; Di Giacomo D; Pierini V; Gorello P; Barba G; Lema Fernandez AG; Pellanera F; Iannotti T; Falzetti F; La Starza R; Mecucci C
    Mol Cytogenet; 2016; 9(1):68. PubMed ID: 27594918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.
    Beer PA; Delhommeau F; LeCouédic JP; Dawson MA; Chen E; Bareford D; Kusec R; McMullin MF; Harrison CN; Vannucchi AM; Vainchenker W; Green AR
    Blood; 2010 Apr; 115(14):2891-900. PubMed ID: 20008300
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhang Y; Bi H; Wang Y; Chen L; Pan J; Xu P; Wang W; Yang S
    Blood Sci; 2022 Oct; 4(4):199-204. PubMed ID: 36518237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of Laboratory and Clinical Feature in the Patients with Myeloproliferative Neoplasm Co-expression of BCR-ABL1 and JAK2 V617F].
    Yuan XG; Wan RT; Zhao XW; Yang XZ; Xiao J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1236-1241. PubMed ID: 34362508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myeloproliferative disorders: a tyrosine kinase tale.
    De Keersmaecker K; Cools J
    Leukemia; 2006 Feb; 20(2):200-5. PubMed ID: 16341034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia.
    Jelinek J; Oki Y; Gharibyan V; Bueso-Ramos C; Prchal JT; Verstovsek S; Beran M; Estey E; Kantarjian HM; Issa JP
    Blood; 2005 Nov; 106(10):3370-3. PubMed ID: 16037387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of JAK2 V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan.
    Tabassum N; Saboor M; Ghani R; Moinuddin M
    Pak J Med Sci; 2014 Jan; 30(1):185-8. PubMed ID: 24639858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique three-way Philadelphia chromosome variant t(4;9;22)(q21;q34;q11.2) in a newly diagnosed patient with chronic phase chronic myeloid leukemia: a case report and review of the literature.
    Torii Y; Nanjo K; Toubai T; Hosokawa M; Sato R; Yamada A; Aizawa K; Himuro M; Ito S; Yamamoto M; Magenau J; Wilcox R; Ishizawa K
    J Med Case Rep; 2021 May; 15(1):285. PubMed ID: 34030730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.